NuSirt Biopharma   Report issue

For profit Phase 2
Founded: Knoxville TN United States (2007)
Status: Defunct (2022)

Organization Overview

First Clinical Trial
2012
NCT01593605
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

NuSirt Biopharma | Nutraceutical Discoveries, Inc.

Active Ingredients

Drugs in Phase 2 Trials (4)

leucine (2 trials)

metformin (glucophage) (1 trial)

sildenafil (viagra) (2 trials)

sitagliptin (januvia) (3 trials)

Drugs in Other Trials (1)

resveratrol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 2)

Fatty Liver (Phase 2)

Liver Diseases (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Obesity (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 5